Diligence memo · auto-generated · as of July 3, 2026
Rio Grande Neurosciences, Inc.
Rio Grande Neurosciences, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Rio Grande Neurosciences, Inc. operates in Other Health Care, based in SAN FRANCISCO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Rio Grande Neurosciences, Inc. has raised $8.9M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.7M on 2015-12-23.
Most recent recorded round closed around 2016-01-08.
Valuation (modeled)modeled
Provath models Rio Grande Neurosciences, Inc. at approximately $21M (range $701K–$161M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.46× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 10.5 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 4.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 74% of Other Health Care peers (5377 compared).
Modeled value ranks above 49% of those peers.
Closest niche peers: Eye Academy of America Ltd., Ruddco Inc., Guest House Holdings, LLC, Cb Therapeutics Inc., Shift Sciences, LLC.
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.